References
Bunn PA (1977) Advances in small cell bronchogenic carcinoma. Cancer Treat Rep 61: 333–342
Cavalli F (1979) Phase II trial of CDDP (II) in advanced malignant lymphoma and small carcinoma of the lung. Preliminary results. Cancer Treat Rep 9: 63
Cutler SJ (1968) End results in cancer. Rep. 3. U.S. Dept. of H.E.W., Public Health Service. GPO. Washington, DC
De Jager RL Kenis Y (1977) Progress in lung cancer treatment: in Recent Advances in Cancer Treatment. Raven Press, New York, pp 131–147
Dombernowsky P (1976) Treatment of small cell anaplastic carcinoma of the lung with an oral solution of VP16-213. A phase II trial. Proc Am Soc Clin Oncol 17: 280
Roswit B (1968) The survival of patients with inoperable lung cancer: A large scale randomized study of radiation therapy vs. placebo. Radiology 90: 688–697
Selawry OS (1974) The role of chemotherapy in the treatment of lung cancer. Semin Oncol 1:259–272
Sierocki JS (1979) Cis-diamminedichloroplatinum (II) and VP16-213: An active induction regimen for small carcinoma of the lung. Cancer Treat Rep 63: 1593–1597
Tucker RD (1978) Chemotherapy of small cell carcinoma of the lung with VP16-213 Cancer 41: 1710–1714
Wasserman TH (1975) Tabular analysis of the clinical chemotherapy of solid tumors. Cancer Treat Rep 6: 399–419
Weiss RB (1978) Small cell carcinoma of the lung: Therapeutic management. Ann Int Med 88: 522–531
Zingo L (1975) I fattori prognostici, in I tumori polmonari. Ambrosiana, Milano, pp 203–208
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Madrigal, P.A., Manga, G.P., Palomero, I. et al. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC). Cancer Chemother. Pharmacol. 7, 203–204 (1982). https://doi.org/10.1007/BF00254549
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254549